Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate

CONCLUSIONS: The plasma trough concentration of ABI is associated with the presence of AEs and treatment failure after AA administration. ABI concentration monitoring may be useful in patients with prostate cancer who received AA.PMID:36378297 | DOI:10.1007/s00228-022-03420-0

Source: Clinical Prostate Cancer - November 15, 2022 Category: Cancer & Oncology Authors: Yoshiko Takahashi Shintaro Narita Masaki Shiota Masatomo Miura Hideaki Kagaya Soki Kashima Ryohei Yamamoto Taketoshi Nara Mingguo Huang Kazuyuki Numakura Mitsuru Saito Masatoshi Eto Tomonori Habuchi Source Type: research